Albendazole therapy for neurocysticercosis.

Abstract

Seven patients with chronic parenchymal brain cysticercosis were treated with albendazole for one month at daily doses of 15 mg/kg of body weight. Computed tomographic follow-up studies were made at the following times: a mean of 16 months before the trial; the beginning of treatment; the end of treatment; and three months afterward. Computed tomographic… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.